Determination of venlafaxine in human plasma and bioequivalence with HPLC-MS/MS
Li Guo
Abstract
Li Guo
Abstract
Objective To investigate the bioequivalence of venlafaxine hydrochloride capsules in Chinese healthy volunteers.Methods 50 mg test preparation and reference preparation were given to 24 male healthy volunteers in randomized two-way crossover design and blood samples in 36 h were collected.HPLC-MS/MS was used to determine plasma concentrations of venlafaxine.The pharmacokinetics and relative bioavailability were calculated by DAS to evaluate bioequivalence.Results The main pharmacokinetic parameters of the two preparation were as follows: Cmax were(59.32±17.21) and(60.58±17.42) μg·L-1,Tmax were(2.08±0.46) and(2.25±0.55) h,T1/2 were(6.69±1.67) and(6.35±1.69) h,AUC0-36 were(524.65±227.01) and(528.22±226.57) μg·L-1·h,AUC0-∞were(544.81±246.05) and(546.85±244.62) μg·L-1·h,respectively.The mean relative bioavailability of test preparation and reference preparation were(100.37±10.41)%.Conclusion The statistical analysis shows the two preparations are bioequivalent.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the bioequivalence of venlafaxine hydrochloride capsules in Chinese healthy volunteers.Methods 50 mg test preparation and reference preparation were given to 24 male healthy volunteers in randomized two-way crossover design and blood samples in 36 h were collected.HPLC-MS/MS was used to determine plasma concentrations of venlafaxine.The pharmacokinetics and relative bioavailability were calculated by DAS to evaluate bioequivalence.Results The main pharmacokinetic parameters of the two preparation were as follows: Cmax were(59.32±17.21) and(60.58±17.42) μg·L-1,Tmax were(2.08±0.46) and(2.25±0.55) h,T1/2 were(6.69±1.67) and(6.35±1.69) h,AUC0-36 were(524.65±227.01) and(528.22±226.57) μg·L-1·h,AUC0-∞were(544.81±246.05) and(546.85±244.62) μg·L-1·h,respectively.The mean relative bioavailability of test preparation and reference preparation were(100.37±10.41)%.Conclusion The statistical analysis shows the two preparations are bioequivalent.
Key concepts: Bioequivalence, Cmax, Bioavailability, Pharmacokinetics, Venlafaxine, Chromatography, Crossover study, Venlafaxine Hydrochloride